<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Distinguishing features between acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) and transverse myelitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Distinguishing features between acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) and transverse myelitis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Distinguishing features between acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) and transverse myelitis</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="20%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Characteristics</td> <td class="subtitle1">Acute myelitis</td> <td class="subtitle1">Guillain-Barré syndrome</td> <td class="subtitle1">Distinguishing features</td> </tr> <tr> <td>Motor findings</td> <td>Paraparesis or quadriparesis</td> <td>Ascending weakness LE&gt;UE in the early stages</td> <td> <p>Myelopathy: if UE involvement, often as severe as LE; often no UE involvement.</p> GBS: there usually is UE involvement and it is less severe than LE involvement early in the disease.</td> </tr> <tr> <td>Sensory findings</td> <td>Typically with a spinal cord sensory level demarcating intact (above) from diminished (below) pin and light touch sensation</td> <td>Ascending sensory loss LE&gt;UE in the early stages</td> <td> <p>Myelopathy: sensory level usually identified; often no arm involvement.</p> GBS: no sensory level; usually UE less affected than LE early in the disease.</td> </tr> <tr> <td>Autonomic findings</td> <td>Early loss of bowel and bladder control</td> <td>Autonomic dysfunction of the cardiovascular system</td> <td> <p>Myelopathy: urinary urgency or retention early and prominent; cardiovascular instability only in severe cases higher than T6 spinal level.</p> GBS: urinary urgency or retention less common; cardiovascular instability is more common.</td> </tr> <tr> <td>Cranial nerve findings</td> <td>None</td> <td>Extra-ocular muscle palsies or facial weakness</td> <td>GBS: cranial neuropathies are more common than in acute myelopathy.</td> </tr> <tr> <td>Electrophysiologic findings</td> <td> <p>EMG/NCS findings may be normal or may implicate the spinal cord</p> Prolonged central conduction on SEP latencies or missing SEP in conjunction with normal sensory nerve action potentials</td> <td>EMG/NCS findings confined to the peripheral nervous system: motor and/or sensory nerve conduction velocity reduced, distal latencies prolonged; conduction block; reduced H reflex usually present</td> <td> <p>The lack of peripheral nerve abnormalities in a patient with progressive weakness and sensory loss should suggest evaluation of the spinal cord for pathology.</p> Conversely, patients with suspected acute myelopathy but equivocal clinical, laboratory, or radiologic findings may warrant peripheral nerve examination.</td> </tr> <tr> <td>MRI findings</td> <td>Usually a focal area of increased T2 signal in the spinal cord, with or without gadolinium enhancement</td> <td>May be normal, or may reveal thickening and enhancement of the intrathecal spinal nerve roots and cauda equina. Abnormalities of the posterior columns are described in exceptional cases of Miller Fisher syndrome.</td> <td>MRI abnormalities may be helpful in diagnosing a patient who is suspected of having GBS from acute myelopathy.</td> </tr> <tr> <td>CSF</td> <td>Usually, CSF pleocytosis and/or increased IgG index</td> <td>Usually, elevated protein in the absence of CSF pleocytosis</td> <td>CSF pleocytosis and elevated IgG index may be helpful in diagnosing a patient who is suspected of having GBS from acute myelopathy.</td> </tr> </tbody></table></div><div class="graphic_footnotes">LE: lower extremity; UE: upper extremity; GBS: Guillain-Barré syndrome; EMG: electromyography; NCS: nerve conduction study; SEP: somatosensory evoked potentials; MRI: magnetic resonance imaging; CSF: cerebrospinal fluid; IgG: immunoglobulin G.</div><div id="graphicVersion">Graphic 88912 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
